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ABSTRACT
Background: Estrogen plays a key role in human physiological processes. 
Polymorphisms of estrogen receptors have been implicated in the development 
of numerous diseases. The aim of this study was to evaluate the frequency 
of ERα gene Pvull and Xbal polymorphisms and assessing their association 
with CD4+ T-cell counts in HIV-infected children on highly active antiretroviral 
therapy. 
Methods: CD4+ T cell counts were determined using the FACS count system. 
ERα PvuII and XbaI polymorphisms were analyzed by PCR-RFLP. 
Results: This study enrolled 34 HIV-infected children on HAART. The 
frequencies of the PvuII and XbaI gene polymorphisms were PP 41,2%, Pp 
26,5%, pp 32,4% and XX 35,3%, Xx 17,6%, xx 47,1% respectively. CD4+ T-cell 
counts were significantly associated with XbaI polymorphisms (p<0.05), but not 
PvuII polymorphisms (p>0.01). 
Discussion: Host genetic factor polymorphism is an important determinant 
of HIV disease progression and treatment response. The ERα Pvull and Xbal 
polymorphisms can increase risk for the development of HIV-related complication, 
including oral diseases. 
Conclusion: The ERα gene XbaI polymorphism was significantly associated 
with CD4+ T-cell counts. It may explain the role of estrogen in the regulation of 
HIV replication. Studying human genetic variation in HIV-infected individuals is 
important to guide a new therapeutic approach.
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INTRODUCION 
Estrogen is one form of the class of steroid 
hormone that consists of estradiol (E2), 
estrone and estriol. Estrogen plays a key role 
in many human physiological processes that 
range from the development and maintenance 
of reproductive organs to the regulation of 
cardiovascular, musculoskeletal, immune, 
and central nervous system homeostasis.1-3 
Physiological and metabolic effects of 
estrogens are mediated by the nuclear estrogen 
receptors (ERs), named estrogen alpha (ERα) 
and estrogen receptor beta (ERβ), which 
distinct tissue and cell patterns of expression.3,4 
The common ERs polymorphisms associated 
with the expression of the estrogen receptors 
are PvuII (IVS1–397 T/C; rs2234693) and XbaI 
(IVS1–351 A/C; rs9340799) that are the most 
widely studied so far.5 
It has been shown that ERs receptors 
have been detected in oral mucosa and 
salivary glands. The presence of ER mRNA 
and immunoreactive ER protein suggests that 
estrogens have a biological role in oral mucosa 
and salivary glands.6,7 Throughout the last year, 
an increasing number of studies have studied the 
relationships between genetic polymorphisms 
of PvuII and XbaI and numerous diseases. As 
the oral mucosa contains estrogen receptors, 
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variations in estrogen levels can affect oral 
mucosa directly or through neural mechanism 
affect the oral cavity.8 The previous findings 
showed that estrogen may be involved in the 
development or progression of numerous 
oral diseases, including oral leukoplakia, oral 
squamous cell carcinoma (OSCC), periodontal 
disease, xerostomia, burning mouth syndrome 
(BMS), and temporomandibular joint disorders 
(TMJD).9-11 
The amount of attention has been given to the 
relationship between estrogen and HIV. It has 
been demonstrated a contribution of estrogen 
for HIV-1 replication through ERα by augmenting 
Sp1 DNA-binding and transcriptional activity.12 
In addition, antiretroviral drugs, such as non-
nucleoside reverse transcriptase inhibitors, 
have been showed to be associated with 
increased levels of estrogen.13 It is rare to 
find recent data on estrogen and its receptor 
in HIV-infected population, especially in HIV-
infected children. While children with advanced 
immunosuppression may frequently develop 
estrogen-related diseases, including in oral 
cavity. At present, genotype distribution of ERα 
gene Pvull and Xbal polymorphisms and their 
association with HIV-diseases progression has 
not been reported. It is known well that HIV 
infection and AIDS among children continues 
to be a significant problem in developing 
countries including in Indonesia. This study was 
conducted to find out an association between 
ERα gene Pvull and Xbal polymorphisms with 
CD4+ T-cell counts as a marker of the degree 
of immunosuppression in HIV-infected children 
on highly active antiretroviral therapy (HAART).
METHODS
Ethics Statement
The study protocol was reviewed and 
approved by Ethical Committee of Faculty of 
Medicine, Universitas Padjadjaran number 
275/UN6.C1.3.2/KEPK/PN/2015. All the 
parents of children provided written informed 
consent.
Study participants 
The present study enrolled 34 (thirty-four) 
HIV-infected children under HAART, aged 
between 6 and 14 years. All study participants 
were diagnosed HIV positive at Dr. Hasan 
Sadikin General Hospital.
CD4+ T cell count, genomic DNA extraction 
and polymorphisms analysis 
Blood samples were collected from the 
study participants and the CD4+ T-cell counts 
were determined using the Becton Dickinson 
(BD) FACS Count system. The genomic DNA 
was extracted from whole blood using the 
established protocol for DNA extraction from 
blood cells. The PvuII and XbaI polymorphisms 
of ERα were analyzed by polymerase 
chain reaction restriction fragment length 
Polymorphism (PCR-RFLP) as described 
previously.15
Statistical analysis 
Data entry and analysis were done using 
software SPSS version 13. Quantitative 
data were presented by mean and standard 
deviation. Qualitative data were presented by 
frequency distribution. One-way ANOVA and 
Kruskal-Wallis test were used to detect the 
mean difference across the two genotypes and 
the CD4+ T-cell counts. A confidence interval 
(CI) level was set to 95% where any output p 
< 0.05 would be interpreted as an indicator of 
statistical significant.  
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RESULTS 
Characteristics of the study participants
The distributions of characteristics of 
the thirty-four (34) HIV-infected children on 
HAART recruited in this study are summarized 
in Table 1. The gender distributions of the 
study participants were 16 (47,1 %) males and 
18 (52,9 %) females. Their mean age was 9 
years (SD ± 3), ranging from 6 to 14 years. 
The mean duration of HAART use was 5 years. 
The mean CD4+ T-cell counts of the study 
participants was 724 (18 – 1805) cell/mm3 and 
8 participants reported to have CD4 count < 
200 cells. Distribution of CD4+ T-cell counts of 
the study participants was shown in Tabel 2. 
The mean of CD4+ T-cell counts of the study 
participants was cell/mm3, and 8 participants 
reported to have severe immunosuppression 
(<200/mm3) < 200 cell/mm3.
Genotype frequency and its association 
with the CD4+ T-cell counts
The genotype distributions of the ERα 
gene Pvull and Xbal polymorphism among 
HIV-infected children on HAART are shown 
in Table 3. Genotype Pvull polymorphism was 
distributed as follows: PP 41,2%  (n=14), Pp 
26,5% (n=9), pp 32,4% (n=11). The frequency 
of Xbal polymorphism was XX 35,3% (n=12), 
Tabel 1. Characteristics of the study participants
Table 2. CD4 T-cell counts in relation to the degree of immunosuppression of the study 
participants.
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Table 4. Analysis of the association between ESRα gene Pvull and Xbal polymorphisms and 
CD4+T-cell counts in HIV-infected children on HAART
Figure 1. Distribution of the association of the ESRα Pvull polymorphisms (A) and Xbal 
polymorphisms (B) with CD4+ T-cell counts in HIV-infected children on HAART. 
Table 3. Frequency distribution of the ESRα gene Pvull and Xbal polymorphisms in HIV infected 
children on HAART. 
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Xx 17,6% (n=6), xx 47,1% (n=16). Analysis for 
the association of ERα gene Pvull and Xbal 
polymorphism with CD4+ T-cell counts were 
shown in Table 4. It was observed significant 
association of the Xbal polymorphism with 
CD4+T-cell counts (p<0.05). In subjects with 
Xx and xx genotype have a higher median of 
CD4+T-cell counts than in subjects with XX 
genotype. Whereas, there was no significant 
association were seen for Pvull polymorphism 
with CD4+ T-cell counts. 
DISCUSSION 
Host genetic factors have been shown 
to have an important role as a determinant 
of HIV disease progression.15 HIV-disease 
progression in young children is more rapidly 
than in adults, the effects of host genetic 
factors on HIV disease progression may be 
more clearly identified. It has been suggested 
that host genetic polymorphisms influence 
the risk of developing numerous diseases in 
HIV-infected people.16-18 Estrogene hormone 
is well known to play an essential role in the 
growth and development during childhood 
and estrogen receptors (ERs) mediate much 
estrogen action. 
In this study, we have analyzed the 
frequency distribution of the ESRα Pvull and 
Xbal polymorphisms in HIV-infected children on 
HAART and their association with CD4+T-cell 
counts. Clinical monitoring of infected persons 
relies on monitoring of CD4+T-cell counts 
and viral load used as a predictor of disease 
progression and the risk for development 
of HIV-related complication. Our data 
showed that PP genotype of ERα gene Pvull 
polymorphism more frequent than Pp and pp 
genotype. Whereas, the frequencies of xx and 
Xx genotype of ERα gene Xbal polymorphism 
were higher than XX genotype. Furthermore, 
Xbal polymorphisms significantly associated 
with CD4+T-cell counts in HIV-infected children 
on HAART. While, there was no significant 
association were seen for Pvull polymorphism 
with CD4+ T-cell counts. In subjects with Xx and 
xx genotype have a higher median of CD4+T-
cell counts than in subjects with XX genotype. 
It has been reported the direct inhibitory effect 
of 17β-estradiol, the most bioactive form 
of estrogen, inhibits HIV replication.19 Prior 
studies has been reported that the common 
ERα polymorphisms and XbaI and PvuII as 
possible markers for several human diseases 
and these genotype variations have been 
implicated in the occurrence of numerous 
diseases.20-22
The host genetic factors may alter the 
response to antiretroviral. HAART is well-
established have an important role to reduce 
the frequency of opportunistic infections and 
the number of AIDS-related deaths. However, 
the adverse effects of HAART use have been 
reported with the use of all antiretroviral 
(ARV) drugs.23 Prior studies demonstrated the 
influence of antiretroviral therapy on growth 
hormone therapy in HIV-infected patients. Non-
nucleoside reverse transcriptase inhibitors 
were associated with 17beta-estradiol, the 
most bioactive form of estrogen.24 It has also 
been reported that genetic polymorphisms of 
estrogen receptors in HIV-infected patients 
on HAART.25 Another study suggested that 
the efavirenz directly induced growth tissue 
through direct binding and modulation of 
estrogen receptor.26 
Estrogen receptors have been detected in 
oral mucosa and salivary glands, hence it is 
suggested that estrogens have a biological 
role in oral mucosa and salivary glands. 
Prior studies have been reported that some 
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genetic changes had any effect on oral cavity. 
These findings could be applicable in oral 
health therapy. Besides, other factors such 
as microorganisms, chronic irritation and 
sex hormones along with underlying genetic 
factors may also contribute to pathogenesis 
of oral diseases.9-11 Genetic polymorphisms 
of estrogen receptors related to oral disease 
have not been investigated by any study so 
far. Recognition of the susceptibility genes for 
HIV-related oral diseases may also important 
to initial prevention of disease.
The present study had some limitations. 
The size of the population studied was 
relatively small. Therefore, a larger population 
is required to establish the potential role of the 
genetic polymorphisms of estrogen receptors 
as a modifier gene in disease progression 
in HIV population. During the past decade, 
the majority of studies investigating the 
influence of human genetic variation related 
to HIV disease and treatment response. Much 
research has established that host genetic 
factors are important determinants HIV disease 
progression in children as well as adults. 
Several anti–HIV-1 gene therapy approaches 
have been studied, including T-cells gene 
therapy as co-option for anti-HIV treatment.27 
The impact of human genetic variation on HIV 
pathogenesis and treatment response is a 
complex multi factorial phenomenon, which still 
remains to be fully elucidated and understood.
CONCLUSIONS
We summarized that the ERα gene Xbal 
polymorphism significantly associated with 
CD4+T-cell counts in HIV-infected children 
on HAART. The relationship between genes 
determining disease progression and drug 
response requires much further study focus 
on the role of ERα that may help to identify 
therapeutic or diagnostic markers. HIV-
infected children are at increased risk for 
growth and development disorders and 
estrogen-associated diseases, which might be 
influenced by a number of genotypic factors. 
These findings emphasize the important of 
studying human genetic variation to guide a 
new therapeutic approach. A comprehensive 
study of the molecular genetic variation can be 
used to predict pharmacological response. 
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